European Archives - Page 74 of 1506 - European Medical Journal

Wildlife Trade Raises Zoonotic Disease Risk Over Time

Wildlife trade increases pathogen sharing with humans, with each decade in trade linked to one additional zoonotic pathogen per species.

Is IVF More Successful in the Spring?

In patients undergoing IVF, more favourable outcomes may be observed in the springtime, researchers have reported in a 2026 retrospective cohort study.

Virtual Exchange Strengthens Students' Ethical and Patient Safety Competence

Virtual Exchange Strengthens Students' Ethical and Patient Safety Competence

In response to growing calls for the internationalisation of radiography education, a sustained biennial virtual exchange was established…

15 Apr 2026

MASH and The Race for Liver Antifibrotics

Metabolic dysfunction-associated steatohepatitis (MASH), along with other chronic liver diseases, leads to progressive fibrosis and…

Heart Failure Predicted Up to Five Years Early

In this study of 72,751 adults without prior heart failure or myocardial infarction, researchers used automated imaging analysis to extract over 1,600 radiomic features from epicardial fat captured during coronary CT angiography.

Exterior of glass AWS office building

Amazon launches AI platform for faster drug discovery

Amazon Web Services has launched a new AI platform to help drug developers identify and test potential candidates.

EAACI 2026 Interview: María Torres

As President of EAACI and of the 2026 Congress, how would you describe the scientific and clinical priorities shaping this year’s…..

Complete Tumour Regression in Novel Brain Cancer Treatment Model

A new glioblastoma treatment showed tumour elimination and durable protection in a preclinical model. Discover what this means for future therapies. Read more.

England Relaunches Women’s Health Strategy Amid “Medical Misogyny”

The UK Government has relaunched the Women’s Health Strategy for England on 14th April 2026, following select committee findings of “medical misogyny” in the NHS.

Tuberculosis Vaccine Trial Shows Limited Overall Protection

A phase 3 trial of two tuberculosis vaccines shows limited overall protection but meaningful efficacy against extrapulmonary disease in selected groups.